Search

Your search keyword '"Mueller-Tidow, Carsten"' showing total 12 results

Search Constraints

Start Over You searched for: Author "Mueller-Tidow, Carsten" Remove constraint Author: "Mueller-Tidow, Carsten" Publisher amer soc hematology Remove constraint Publisher: amer soc hematology
12 results on '"Mueller-Tidow, Carsten"'

Search Results

1. Treatment Response and Long-Term Survival in Multiple Myeloma in the GMMG-HD4 Trail - Neither Profit All Molecular Entities Alike, Nor Are Remissions to Different Regimen Equal

2. Outcome of Patients with Acute Myeloid Leukemia (AML) Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Beyond First Complete Remission (CR1)

3. Salvage Autologous Transplant and Lenalidomide Maintenance Versus Continuous Lenalidomide/Dexamethasone for Relapsed Multiple Myeloma: Results of the Randomized GMMG Phase III Multicenter Trial Relapse

4. Subgroup Analyses of the Randomized GMMG Phase III Multicenter Trial Relapse Suggest Survival Benefit of Salvage Autologous Transplant Primarily in Low Risk Multiple Myeloma

5. Salvage Autologous Transplant and Lenalidomide Maintenance Versus Continuous Lenalidomide/Dexamethasone for Relapsed Multiple Myeloma: Results of the Randomized GMMG Phase III Multicenter Trial Relapse

6. Treatment Response and Long-Term Survival in Multiple Myeloma in the GMMG-HD4 Trail - Neither Profit All Molecular Entities Alike, Nor Are Remissions to Different Regimen Equal

7. Outcome of Patients with Acute Myeloid Leukemia (AML) Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Beyond First Complete Remission (CR1)

8. Subgroup Analyses of the Randomized GMMG Phase III Multicenter Trial Relapse Suggest Survival Benefit of Salvage Autologous Transplant Primarily in Low Risk Multiple Myeloma

9. Allogeneic Stem Cell Transplantation Versus Conventional Postremission Therapy for Acute Myeloid Leukemia in First Complete Remission: A Matched Pairs Analysis

10. Allogeneic Stem Cell Transplantation Versus Conventional Postremission Therapy for Acute Myeloid Leukemia in First Complete Remission: A Matched Pairs Analysis

11. Sorafenib In Combination with Standard Induction and Consolidation Therapy In Elderly AML Patients: Results From a Randomized, Placebo-Controlled Phase II Trial

12. Sorafenib In Combination with Standard Induction and Consolidation Therapy In Elderly AML Patients: Results From a Randomized, Placebo-Controlled Phase II Trial

Catalog

Books, media, physical & digital resources